The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.
本发明提供了化合物、其组合物以及使用方法。这些化合物包括一个IRAK结合基团和一个降解诱导基团(DIM)。DIM可以是DTM、一个
配体结合基团(LBM)或赖
氨酸类似物。这些化合物可以作为IRAK蛋白激酶
抑制剂,并应用于IRAK介导的疾病。